Dr. Reddy’s acquires Mayne Pharma’s US prescription portfolio for $105 mn
[ad_1] Chennai: Indian pharma major, Dr. Reddy’s Laboratories Ltd, through its subsidiary has inked an agreement to acquire the US generic prescription product portfolio of the Australia-based, Mayne Pharma Group Limited, for consideration of about $105 million. According to Dr. Reddy’s, $90 million will be paid upfront in cash and there will be contingent payments … Read more